Evidence map›Paper›PMID 40698926›Full record

ReviewACS applied materials & interfaces2025

Surface-Modified Nanozymes for Enhanced and Selective Catalysis.

Xinghua Chen, Itamar Willner

Abstract readReview
In one paragraph

Review in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Nanozyme-Driven Ferroptosis-Cuproptosis Interplay in Lung Cancer.International journal of nanomedicine · 2026
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xinghua ChenInstitute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Itamar WillnerInstitute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.ORCID 0000-0001-9710-9077

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surface-modified catalytic nanoparticles (nanozymes) are introduced as hybrid nanoparticles overcoming basic limitations associated with bare nanozymes that include moderate catalytic turnovers, lack of substrate selectivity and chiroselectivity, and poor or nonselective permeabilities into biomembrane. This review introduces aptamer-modified nanozymes, receptor (cyclodextrins)- or ligand (amino acids, peptides)-functionalized catalytic nanoparticles, and molecularly imprinted polymer-coated nanozymes as hybrid frameworks improving the catalytic properties and selective/chiroselective functions of the nanozymes. Binding of the reaction substrates to the aptamers, ligands, or molecular-imprinted sites, by affinity interactions, concentrates the substrates in spatial proximity to the nanozyme catalytic sites ("molarity effect"), thereby enhancing the catalytic performance of the frameworks. Specific and chiroselective binding interactions of the substrates to the surface modifiers lead to selective or chiroselective chemical transformations. Moreover, by appropriate molecular engineering of the surface modifiers on the nanozymes, catalytic functions lacking in the parent bare nanozymes are demonstrated. Potential applications of surface-modified nanozymes are discussed.

Indexed as

NanoparticlesCatalysisCyclodextrinsMolecular ImprintingPeptidesSurface PropertiesCyclodextrinsPeptidesAptamerChiroselectivityMolecular-imprinted polymerNanomedicineNanoparticleReactive oxygen species (ROS)

Identifiers

PMID40698926
PMCPMC12332837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.